Literature DB >> 22123288

Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.

Anna M Adamusiak1, Olga Stasikowska-Kanicka, Anna Lewandowska-Polak, Marian Danilewicz, Malgorzata Wagrowska-Danilewicz, Andrzej Jankowski, Marek L Kowalski, Rafal Pawliczak.   

Abstract

BACKGROUND: The pathogenesis of rhinosinusitis in aspirin-exacerbated airway disease is closely linked to the disequilibrium in arachidonic acid metabolism. Although considerable amounts of data concerning impaired eicosanoid production are available, the precise mechanism and pathogenesis of the disease are still unknown. The aim of the present study was to assess the expression of enzymes belonging to the arachidonic acid cascade and receptors for arachidonate derivative metabolites in nasal polyps from aspirin- hypersensitive (AH) and aspirin-tolerant (AT) patients with rhinosinusitis.
METHODS: Cells expressing cysteinyl leukotriene (CysLT) receptors (CysLT(1) and CysLT(2)), arachidonate 5-lipoxygenase, leukotriene B(4) receptor type 1, E-prostanoid receptors (EP(2) and EP(4)), cyclooxygenase (COX)-1 and COX-2 were detected by immunocytochemistry in nasal polyps obtained from 10 AH patients and 18 AT patients.
RESULTS: There was a significantly higher density of cells expressing CysLT(1) and CysLT(2) receptors in nasal polyps from AH patients than from AT patients (p < 0.001). In contrast, the density of cells expressing EP(2) receptor and COX-2 was significantly lower in AH patients than in AT patients (p < 0.02). The number of COX-2-positive epithelial cells was significantly reduced in AH polyps (p < 0.04).
CONCLUSIONS: The elevated number of nasal polyp cells expressing CysLT receptors and lack of cells expressing EP(2) receptor and COX-2 may be related to a more severe course of hyperplastic rhinosinusitis in aspirin hypersensitivity.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123288     DOI: 10.1159/000329744

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  Biology of nasal polyposis.

Authors:  Whitney W Stevens; Robert P Schleimer; Rakesh K Chandra; Anju T Peters
Journal:  J Allergy Clin Immunol       Date:  2014-05       Impact factor: 10.793

Review 2.  The role of prostaglandins in allergic lung inflammation and asthma.

Authors:  Dru Claar; Tina V Hartert; Ray Stokes Peebles
Journal:  Expert Rev Respir Med       Date:  2014-12-26       Impact factor: 3.772

Review 3.  Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.

Authors:  Whitney W Stevens; Robert P Schleimer
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

4.  Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.

Authors:  Katherine N Cahill; Benjamin A Raby; Xiaobo Zhou; Feng Guo; Derek Thibault; Andreas Baccarelli; Hyang-Min Byun; Neil Bhattacharyya; John W Steinke; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

5.  Expression of the cysteinyl leukotriene 1 receptor and glucocorticoid receptor-β in nasal polyps.

Authors:  Yong-Hwi An; Sung-Lyong Hong; Doo Hee Han; Chul Hee Lee; Yang-Gi Min; Chae-Seo Rhee
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-03       Impact factor: 2.503

Review 6.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

Review 7.  Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.

Authors:  Joanna Makowska; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 8.  Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity.

Authors:  Liliana Machado-Carvalho; Jordi Roca-Ferrer; César Picado
Journal:  Respir Res       Date:  2014-08-26

Review 9.  What we know about nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  Duy Le Pham; Ji-Hye Kim; Tu Hoang Kim Trinh; Hae-Sim Park
Journal:  Korean J Intern Med       Date:  2016-03-31       Impact factor: 2.884

10.  Release of cyclooxygenase-2 and lipoxin A4 from blood leukocytes in aspirin-exacerbated respiratory disease.

Authors:  Ajnacska Rozsasi; Akos Heinemann; Tilman Keck
Journal:  Allergy Rhinol (Providence)       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.